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doi:10.1Objective: Atrial fibrillation puts patients at significant risk for embolic stroke originating from the left atrial
appendage. Few means are available for safe, effective, and durable left atrial appendage occlusion. A new
clip device was evaluated with regard to safety and effectiveness for epicardial left atrial appendage occlusion.
Methods: Patients with atrial fibrillation undergoing elective cardiac surgery through a median sternotomy were
enrolled for concomitant epicardial clip placement. Early postoperative and 3-month follow-up computed tomog-
raphy studies were used to assess clip stability and left atrial appendage perfusion.
Results: From September 2007 to December 2008, 34 patients underwent successful clip placement. No device-
related complications occurred. Operative mortality was 8.8% and not study or device related. Deployment was
rapid, and left atrial appendage occlusion was confirmed by intraoperative transesophageal echocardiography in
all patients. In addition to excellent clinical outcomes (no stroke/transient ischemic attack), serial computed to-
mography demonstrated stable clip location and appendage perfusion at 3 months in all patients.
Conclusion: Safe, effective, and durable left atrial appendage occlusion can easily be achieved with this new clip.
Further trials are necessary to evaluate the role of the left atrial appendage occlusion in stroke prevention.
(J Thorac Cardiovasc Surg 2010;139:1269-74)E
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SAtrial fibrillation (AF) is a common cardiac arrhythmia
affecting many patients and is associated with increased
mortality independently of other cardiac conditions and
risk factors.1,2 The prevalence of AF and AF-related hospital
admissions is constantly increasing.3 Thromboembolic ori-
gin in AF is often linked to the left atrial appendage
(LAA).4 The gold standard for medical management of
patients with AF remains oral anticoagulation with warfa-
rin.5,6 Percutaneous device occlusion of the LAA remains
challenging.7 The recent Protect AF trial has nevertheless
showed noninferiority of LAA transcatheter device closure
to oral anticoagulation in patients with AF.8 Surgical LAA
occlusion is recommended in the latest AHA/ACC/ESC
guidelines for surgical mitral valve disease6 but also lacks
the desired effectiveness of an ideal therapy.9 With the ad-
vent of minimally invasive techniques to address AF, strat-
egies to obtain LAA occlusion remain challenging and aree Clinic for Cardiovascular Surgerya and Institute of Diagnostic Radiology,b
ersity Hospital Zurich, Switzerland.
ures: S.P.S. reports consulting fees and grant support from Atricure. This study
upported by a grant from Atricure, the manufacturer of the LAA clip. All ab-
technology was purchased as part of standard clinical care. The authors had
ontrol of the design of the study, methods used, outcomes parameters, analysis
ta, and production of this article. This research was funded with an unrestricted
rch grant from Atricure Inc. H.A. and L.D. have been supported by the Na-
l Center of Competence in Research, Computer Aided and Image Guided Med-
terventions of the Swiss National Science Foundation. The trial is registered at
.ClinicalTrials.gov, Reference: NCT00567515.
d for publication March 12, 2009; revisions received May 20, 2009; accepted
blication June 10, 2009; available ahead of print Nov 2, 2009.
for reprints: Sacha P. Salzberg, MD, Clinic for Cardiovascular Surgery, Uni-
y Hospital Zurich, Ra¨mistrasse 100, CH - 8091 Zurich (E-mail: sacha.
erg@gmail.com).
23/$36.00
ht  2010 by The American Association for Thoracic Surgery
016/j.jtcvs.2009.06.033
The Journal of Thoracic and Caroften traumatic to the LAA, even in expert hands.7 In addi-
tion, few data are available to determine the role of LAA oc-
clusion in stroke prevention.10 This first human trial was
designed to evaluate safety and effectiveness of a new
clip11 used for LAA occlusion in patients with AF undergo-
ing cardiac surgery.MATERIALS AND METHODS
From September 2007 to December 2008, patients were enrolled in this
trial at the University Hospital Zurich. Primary inclusion criterion was
elective cardiac surgery in adult patients with AF for whom an ablation
procedure was planned. Patients undergoing a reoperation, with a known
thrombus in the LAA, from the intensive care unit, with a history of pericar-
ditis, who had a recent myocardial infarction (<90 days), and with a known
allergy to the devices component were not allowed to participate (exclusion
criteria). Intraoperative transesophageal echocardiography (TEE) was used
to rule out LAA thrombus at baseline (exclusion criteria) and assess LAA
perfusion at the end of the procedure. Patients returned to the University
Hospital Zurich for serial follow-up after 3 months and yearly thereafter
up to 3 years after surgery. Clinical follow-up included clinical status,
laboratory examination, electrocardiogram, chest radiograph and computed
tomography (CT) workup.
Research was conducted in accordance with the ethical standards of the
responsible committee on human experimentation (institutional and
national) and the Helsinki Declaration of 1975, as revised in 2000.12 All
patients gave informed written consent. The trial is registered at www.
ClinicalTrials.gov (Reference: NCT00567515).
Device Description
The LAA clip system consists of a self-closing, sterile, implantable clip
with a reusable deployment tool (Figure 1, A). The device is applied epicar-
dially (Figure 1, B) and has been previously described.11,13 In addition, a dis-
posable selection guide is used to choose the appropriate clip size. For human
use, the clip is available in 4 sizes (35 mm, 40 mm, 45 mm, and 50 mm). When
closed, the clip applies uniform pressure over the length of the 2 parallel
branches to ensure consistent, reproducible, and secure occlusion of the LAA.diovascular Surgery c Volume 139, Number 5 1269
Evolving Technology/Basic Science Salzberg et al
12
E
T
/B
SAbbreviations and Acronyms70AF ¼ aThtrial fibrillationCT ¼ computed tomography
LAA ¼ left atrial appendage
TEE ¼ transesophageal echocardiographyFIGURE 1. LAA clip, deployment tool, and deployment. A, Reusable
Miltex deployment tool as it was used in all cases. LAA clip is loaded
onto the jaws of this tool. B, LAA mobilized within the clip (1), right pul-
monary veins (2), and pulmonary artery (3), and operator’s hand (4) gently
mobilizing the heart to demonstrate the LAA and allow placement of the clip
with the left hand.Computed Tomography Protocol
All scans were performed using a dual-source CT scanner system with
nonionic contrast medium, standard scanning, and image reconstruction pa-
rameters.14 LAA neck diameter was preoperatively measured on curved
multiplanar reformations through the LAA (Figure 2, A, B). The LAA
patency was visually analyzed by 2 experienced independent readers in con-
sensus. Clip stability was assessed using 2 different measures: (1) distance
from the ostium of the circumflex artery to each end of the clip (Figure 2, C)
and (2) angle between a line drawn along the posterior tips of the transverse
processes of the spine and the long axis of the clip (Figure 2, D). Table 1
summarizes the CT findings.
Statistical Analysis
The Kruskal–Wallis test was used to test for significant changes between
the parameters of average heart rate and heart rate variability during scan-
ning, as well as the clip location (ie, distances and angles), LA diameters,
and LV function parameters across the CT examinations at different dates.
Statistical analysis was performed using commercially available software
(SPSS, release 15.0, Chicago, Ill).
RESULTS
Summary
A total of 34 patients underwent cardiac surgery with con-
comitant LAA clip placement. Patients’ median age was 71
 10 years, and 58% were men. Mean preoperative logistic
EuroScore was 10%  3%, and mean left ventricular func-
tion was 58% 14%. Classification of AF was paroxysmal
(n ¼ 14, 42%), persistent (n ¼ 8, 23%), or permanent
(n ¼ 12, 35%); the mean duration of AF before surgery
was 4  1.5 years. Procedures performed were mitral valve
repair (n ¼ 11), mitral and tricuspid valve repair (2), mitral
repair and aortic valve replacement (3), aortic valve replace-
ment with mitral and tricuspid repair (1), aortic valve
replacement (5), composite graft (1), coronary artery bypass
grafting (7), and combined valve and coronary artery bypass
grafting (4). All patients underwent bipolar radiofrequency
pulmonary vein isolation off pump, or if on-pump, before
aortic crossclamping with intraoperative conduction block
confirmation. In patients with paroxysmal AF addressed
for isolated myocardial revascularization, a complete off-
pump approach was used (n ¼ 5). Patients requiring an
aortic valve procedure underwent on-pump pulmonary
vein isolation (n¼ 8). In the presence of persistent or perma-
nent AF, cardiopulmonary bypass was used, and a complete
left atrial lesion set was performed (n¼ 21, 62%). Left atrial
lesions included a posterior connecting lesions to connect
the epicardial pulmonary vein lesions, one connecting lesion
to the LAA before clip placement and one line from thee Journal of Thoracic and Cardiovascular Suratriotomy down to the mitral valve annulus. If a history of
atrial flutter was present (n ¼ 7), additional right-sided
lesions were performed.
Operative mortality occurred in 3 patients (8.8%). Cause
of death was iatrogenic lung bleed after chest tube injury
(postoperative day 1), acute postoperative hepatic failure
(postoperative day 16), and aortic tear at aortotomy suture
line (postoperative day 20). There was 1 additional death
after discharge that resulted from over-anticoagulation
(international normalized ratio, 4.4) and subsequent out-
of-hospital pericardial tamponade (postoperative day 24).
Autopsy, institutional, and external review excluded any
link to the device or study participation.Clip Placement
TEE confirmed the absence of spontaneous echo contrast
in all patients (exclusion criteria), as also seen on baseline
CT scans. For clip placement, the heart was mobilized
(Figure 1) to develop the base of the LAA, which was then
assessed with the selection guide. Once the clip was loaded
into the reusable deployment tool, while still mobilizing the
heart, the primary surgeon placed the clip on the LAA, which
was gently mobilized by the first assistant with an atraumatic
forceps. When judged satisfactory, located at the base of the
LAA, transversally to the roof of the left atrium, the clip was
deployed (Figure 1, B). When performing a mitral valve re-
placement, the clip was applied before inserting the prosthe-
sis. In all other cases with cardiopulmonary bypass, the clip
was applied just before opening the aortic crossclamp. In thegery c May 2010
FIGURE 2. CT imagery. A, Curved multiplanar CT reformation demon-
strating the plane for measurements of the LAA neck diameter (arrow to
black line). B, Oblique-transverse thick maximum intensity projection CT
images showing the 2 distance measurements (arrow to thin white lines)
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Soff-pump setting, the clip was applied after myocardial re-
vascularization was completed to ensure sufficient coronary
perfusion during cardiac mobilization. No clip repositioning
was necessary. In all patients, satisfactory placement at the
base of the LAA was achieved in a single attempt and
swiftly. The pericardium was closed in all. Postoperatively,
TEE confirmed LAA occlusion in all patients. Procedural
success rate was 100%.
Postoperative Course
In regard to the device or study participation, no compli-
cations occurred. Anticoagulation and platelet aggregation
were managed according to standard clinical practices, that
is, all patients received Coumadin and Amiodarone for 6
months until sinus rhythm was documented on 24-hour Hol-
ter electrocardiogram. Patients were sent to the regular ward,
at which time the first follow-up CT was performed (n ¼
30). Chest radiographs in both anteroposterior and lateral
views (n ¼ 30) were used to assess clip localization. A pa-
tient who had received a kidney transplant 5 years previ-
ously did not undergo any follow-up CT evaluation. In 3
of the 4 patients with fatal outcomes, no follow-up CT
was performed. In 2 of these patients, TEE performed on
the intensive care unit demonstrated no LAA perfusion,
and chest radiographs showed stable clip localization.
Computed Tomography Findings
Despite AF at baseline (n¼ 19, 56% of patients) and high
heart rate variability across all scans during scanning, the
image quality of all examinations was diagnostic, that is,
all measurements could be made in all patients. LAA neck
diameter was on average 1.9 cm at its most narrow point,
considered the ‘‘landing zone’’ of the clip (Table 1). After
surgery, in all serial CT scans the LAA was completely
occluded, and the clip appeared to remain stable (Figure 3).
All measurements (ie, distances and angles) showed no
significant changes across the serial examination dates
(Table 1). Both left atrial and left ventricular function
showed no significant changes when compared (Table 1).
Follow-up
Clinical follow-up was 100% complete at 3 months
(n ¼ 30). In several patients, no follow-up CT was
performed, in which case serial chest radiographs were
used to assess clip stability. Cardiac rhythm at 3 month fol-
low-up was regular sinus rhythm in 21 patients (70%), AF
in 6 patients (20%, all had permanent AF before surgery),from the ostium of the circumflex artery to both ends of the LAA clip. C,
Volume-rendered CT image demonstrating the measurement of the orienta-
tion of the LAA clip. The angle was measured between 2 lines drawn along
the posterior tips of the transverse processes and along the LAA clip
(arrow).
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TABLE 1. Computed tomography findings before surgery, before discharge, and at 3-month follow-up
Time point Baseline Before discharge 3-Month follow-up
N 34 30 26 P value*
Heart rate (beats/min) 68  11 (52–103) 78  15 (59–113) 71  14 (58–100) <.05
Variability 10  8 (1–27) 9  8 (1–33) 5  4 (1–12) .21
LAA patency Patent, no thrombus None None /
LAA neck (cm) 1.9  0.4 (1.1–2.8) / / /
LAA clip location
First distance to CX (mm) / 18  5 (9–29) 17  4 (12–29) .49
Second distance to CX (mm) / 32  8 (20–49) 34  8 (20–47) .77
Angle (degrees) / 39  22 (11–96) 41  16 (12–70) .51
LA diameter (mm)
LA systolic 48  14 (27–90) 44  9 (28–68) 47  9 (33–68) .65
LA diastolic 45  15 (23–88) 41  10 (20–64) 43  9 (29–63) .46
LV dimensions
ESV 89  57 (27–285) 82  57 (22–297) 87  52 (31–230) .89
EDV 163  74 (82–410) 148  75 (63–410) 166  63 (92–345) .44
SV 74  27 (23–139) 66  29 (22–130) 72  32 (15–134) .60
LV function
CO (L/min) 5.1  2.0 (2.5–8.7) 5.0  2.3 (1.7–9.8) 5.5  1.9 (1.6–8.9) .61
EF (%) 47  14 (25–69) 47  15 (22–69) 50  16 (22–74) .78
Myocardial mass (g) 181  49 (112–270) 184  52 (104–277) 170  55 (22–236) .87
LAA, Left atrial appendage; CX, circumflex coronary artery; LA, left atrium; LV, left ventricle; ESV, end-systolic volume; EDV, end-diastolic volume; SV, stroke volume; CO,
cardiac output; EF, ejection fraction. *Kruskal–Wallis test.
Evolving Technology/Basic Science Salzberg et al
E
T
/B
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induced in 2 patients (6%). At follow-up, no stroke or tran-
sient ischemic attack had occurred in any patients (Table 2).
DISCUSSION
We report the first human application of a new epicardial
clip for concomitant LAA occlusion during cardiac surgery
in patients with AF. Clip placement through a median ster-
notomy was performed rapidly and in one attempt. There
were no clip-related complications. CT provided proof of
absence of LAA thrombus (baseline) and demonstrated
durability and stability of clip occlusion after surgery and
over time.
As part of the classic cut-and-sew Maze procedure,
initially described by James Cox’s group,15 surgical excision
of both atrial appendages was first reported. After a mean
follow-up of more than 5 years, only 1 patient in more
than 200 had a stroke, despite the fact that most patients
were not taking anticoagulation15; however, the causality
of an effective procedure restoring sinus rhythm versus
exclusion of atrial appendages remains uninvestigated.
Since then, surgical epicardial occlusion was evaluated in
the LAAOS trial16 in patients undergoing coronary artery
bypass grafting with increased risk of stroke (CHADS score
> 2). Seventy-seven patients were randomized to LAA
occlusion, by staples or suture, or control. During surgery,
there were 9 LAA injuries that were readily repaired. Predis-
charge LAA occlusion was effective in 45% using sutures
and in 72% using a stapler. These results are similar to other
reports,17 highlighting the main challenge faced when1272 The Journal of Thoracic and Cardiovascular Surattempting to eliminate the LAA safely from the circulation.
This is stressed by a recent echocardiographic follow-up
trial9 on 137 patients who underwent LAA closure by exci-
sion (n ¼ 52) and exclusion by stapler or suture (n ¼ 85)
during cardiac surgery. In addition to an impressive learning
curve affecting outcomes, the authors demonstrated only
40% of successful closures. Furthermore, LAA thrombus
was found in 41% of patients with unsuccessful LAA exclu-
sion versus none with excision. After 6 months, 6 patients
with successful LAA closure (11%) and 12 patients with
unsuccessful closure (15%) had evidence of stroke/transient
ischemic attack. The authors concluded that there is a high
occurrence of unsuccessful surgical LAA closure with
severe neurologic consequences. The present study obtained
100% effective LAA occlusion with no learning curve,
complications, or neurologic events during follow-up.
Effective off-pump clip application was performed in 5 pa-
tients (15%) with paroxysmal AF requiring pulmonary
vein isolation and off-pump coronary artery bypass grafting.
In this setting, this device shows true promise, because LAA
injury, especially in a minimally invasive setting, can be
a serious complication. From preclinical11,13 and current
experience, LAA injury during clip placement was never
an issue.
Catheter-based approaches to closing the LAA have been
reported but remain limited because of the inherent limita-
tions of this approach. The Protect AF trial provides the first
real evidence suggesting that closure of the LAA provides
an alternative strategy to oral anticoagulation for stroke pre-
vention in patients with nonvalvular AF. However, thegery c May 2010
FIGURE 3. Multiple views to the heart in 3-dimensional volume showing clip placement technique preoperatively (A–C) and postoperatively (D–F).
TABLE 2. Clinical follow-up data
Baseline Discharge 3 Mo 12 Mo
N (%) 34 30 30 (100) 22 (73)*
Cardiac rhythm:
Sinus rhythm 15 (44) 18 (60) 21 (70) 17 (77)
Atrial
fibrillation
19 (56) 12 (40) 6 (20) 4 (18)
Atrial flutter 7y (21) 3 (10)
Pacemaker 2 (0.6) 2 (0.6) 1 (5)
Medications:
AADz 21 (62) 29 (97) 28 (93) 10 (45)
Coumadin 15 (44) 27 (90) 22 (73) 11 (50)
Clip stablex 34 (100) 30 (100) 30 (100) 22 (100)
AAD, Antiarrhythmic medication. *Follow-up not complete. yHistory of. zBeta-
blocker or amiodarone. xOn chest radiograph and/or computed tomography.
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this trial as well.8 The authors conclude that a higher rate
of adverse events mainly resulted of peri-procedural compli-
cations, as seen by other investigators.18 In addition, we be-
lieve that anatomic considerations such as the highly
individual variability of the left atrial aperture at the base
of the LAA,19 which we also documented in our preopera-
tive CT imaging, may limit efficacious LAA occlusion
from within. We encountered a very high individual ana-
tomic variability of the LAA. It also appears that the CT
measurements of the LAA neck were not at all correlated
with the final intraoperative clip size chosen with the mea-
suring device. This is mainly due to the variability of the
neck, which is considered the landing zone for the clip.
The dimension of the LAA neck in our series was on average
1.9 cm in diameter, varying from 0.8 to 2.9 cm (Table 1). In
a recent series on LAA anatomy in patients with AF studied
by magnetic resonance imaging, Heist and colleagues19
concluded that a significant heterogeneity in LAA size and
dimension was present. The advantages of a standard epicar-
dial approach for LAA closure are clear. The current clip isThe Journal of Thoracic and Caravailable in 4 sizes. In our experience, we used the 2 smallest
clip sizes (35 and 40 mm) in most cases. The positioning of
the clip is the crucial part of the procedure, because it needs
to be located as low as possible in the region of the LAA
neck on the roof of the left atrium. In addition, we alsodiovascular Surgery c Volume 139, Number 5 1273
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cording to the measuring tool. We believe this minimized the
surface of contact of this foreign body with the roof of the
left atrium, which may have had a protective influence on
outcomes after ablation procedures for AF. Our results com-
pare well with those in the current literature in a dedicated
AF setting. In our experience, LAA clip occlusion did not
significantly affect LA diameters and left ventricular func-
tion, because these remained constant over time. Patients’
well-being was not affected by trial participation.
LIMITATIONS
Because this was a pilot trial, no controls were enrolled.
The trial was not powered to assess stroke prevention.
CONCLUSIONS
LAA clip occlusion is a safe and effective new therapy for
patients with AF. Stroke prevention by LAA occlusions of-
fers a new option for these patients.8 Thoracoscopic ap-
proaches, with or without an ablation procedure, might
provide a new indication for cardiac surgeons. Further clini-
cal trials are necessary to establish this new approach.
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